Literature DB >> 20223216

Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2.

Patrick J Lupardus1, Michael E Birnbaum, K Christopher Garcia.   

Abstract

Interleukin-13 is a cytokine important for development of T helper cell type 2 (Th2) responses and plays a critical role in asthma and allergy. The IL-13 Receptor alpha2 (IL-13Ralpha2) is a receptor for IL-13 lacking canonical Jak/STAT signaling functions. Here we present the crystal structure along with a mutational and biophysical analysis of the IL-13/IL-13Ralpha2 complex. While retaining a similar mode of IL-13 binding to its related signaling receptor, IL-13Ralpha1, IL-13Ralpha2 uses peripheral receptor residues unused in the IL-13/IL-13Ralpha1 complex to generate a larger and more complementary interface for IL-13. This results in a four orders of magnitude increase in affinity, to the femtomolar level, compared to IL-13Ralpha1. Alanine scanning mutagenesis of the IL-13 interface reveals several common "hotspot" residues important for binding to both receptors, but also identifies a prominent IL-13Ralpha2-specific contact. These results provide a framework for development of receptor subtype-selective IL-13 antagonists and indicate a decoy function for IL-13Ralpha2.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223216      PMCID: PMC2850121          DOI: 10.1016/j.str.2010.01.003

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  41 in total

Review 1.  Cytokine modulators as novel therapies for asthma.

Authors:  Peter J Barnes
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

2.  Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling.

Authors:  Michael O Daines; Yasuhiro Tabata; Bradley A Walker; Weiguo Chen; Manoj R Warrier; Saswata Basu; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

3.  Version 1.2 of the Crystallography and NMR system.

Authors:  Axel T Brunger
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

4.  BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation.

Authors:  C A O'callaghan; M F Byford; J R Wyer; B E Willcox; B K Jakobsen; A J McMichael; J I Bell
Journal:  Anal Biochem       Date:  1999-01-01       Impact factor: 3.365

5.  A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha -2 and their rapid mobilization by interferon-gamma.

Authors:  Michael O Daines; Gurjit K Khurana Hershey
Journal:  J Biol Chem       Date:  2002-01-10       Impact factor: 5.157

6.  Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain.

Authors:  D Caput; P Laurent; M Kaghad; J M Lelias; S Lefort; N Vita; P Ferrara
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

7.  Characterization of the interaction between interleukin-13 and interleukin-13 receptors.

Authors:  Kazuhiko Arima; Kazuo Sato; Go Tanaka; Sachiko Kanaji; Tohru Terada; Eijiro Honjo; Ryota Kuroki; Yo Matsuo; Kenji Izuhara
Journal:  J Biol Chem       Date:  2005-05-03       Impact factor: 5.157

8.  The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1.

Authors:  D D Donaldson; M J Whitters; L J Fitz; T Y Neben; H Finnerty; S L Henderson; R M O'Hara; D R Beier; K J Turner; C R Wood; M Collins
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

9.  Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response.

Authors:  Monica G Chiaramonte; Margaret Mentink-Kane; Bruce A Jacobson; Allen W Cheever; Matthew J Whitters; Mary E P Goad; Anthony Wong; Mary Collins; Debra D Donaldson; Michael J Grusby; Thomas A Wynn
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  55 in total

1.  A phase 1, randomized, placebo-controlled, dose-escalation study of an anti-IL-13 monoclonal antibody in healthy subjects and mild asthmatics.

Authors:  Peter Hodsman; Claire Ashman; Anthony Cahn; Erika De Boever; Nicholas Locantore; Adrian Serone; Isabelle Pouliquen
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

2.  Commentary: IL-4 and IL-13 receptors and signaling.

Authors:  Sarah M McCormick; Nicola M Heller
Journal:  Cytokine       Date:  2015-07-14       Impact factor: 3.861

Review 3.  Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease.

Authors:  Steven J Van Dyken; Richard M Locksley
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

4.  N-Glycosylation Regulates Chitinase 3-like-1 and IL-13 Ligand Binding to IL-13 Receptor α2.

Authors:  Chuan Hua He; Chun Geun Lee; Bing Ma; Suchitra Kamle; Augustine M K Choi; Jack A Elias
Journal:  Am J Respir Cell Mol Biol       Date:  2020-09       Impact factor: 6.914

5.  IL-13 induces the expression of 11βHSD2 in IL-13Rα2 dependent manner and promotes the malignancy of colorectal cancer.

Authors:  Li Jiang; Qi Cheng; Binhao Zhang; Mingzhi Zhang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

6.  Chitinase 3-like-1 and its receptors in Hermansky-Pudlak syndrome-associated lung disease.

Authors:  Yang Zhou; Chuan Hua He; Erica L Herzog; Xueyan Peng; Chang-Min Lee; Tung H Nguyen; Mridu Gulati; Bernadette R Gochuico; William A Gahl; Martin L Slade; Chun Geun Lee; Jack A Elias
Journal:  J Clin Invest       Date:  2015-06-29       Impact factor: 14.808

7.  [Brahma-related gene 1 promotes airway mucus hypersecretion via STAT6 in asthmatic mice].

Authors:  Shuang Cai; Wenjing Zou; Ting Wang; Yaping Wang; Fengxia Ding; Daiyin Tian; Chao Niu; Lin Zou; Zhou Fu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-01-30

8.  Allosteric competitive inactivation of hematopoietic CSF-1 signaling by the viral decoy receptor BARF1.

Authors:  Jonathan Elegheert; Nathalie Bracke; Philippe Pouliot; Irina Gutsche; Alexander V Shkumatov; Nicolas Tarbouriech; Kenneth Verstraete; Anaïs Bekaert; Wim P Burmeister; Dmitri I Svergun; Bart N Lambrecht; Bjorn Vergauwen; Savvas N Savvides
Journal:  Nat Struct Mol Biol       Date:  2012-08-19       Impact factor: 15.369

9.  Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity.

Authors:  Dongrui Wang; Brenda Aguilar; Renate Starr; Darya Alizadeh; Alfonso Brito; Aniee Sarkissian; Julie R Ostberg; Stephen J Forman; Christine E Brown
Journal:  JCI Insight       Date:  2018-05-17

10.  Crystallization and preliminary X-ray diffraction analysis of the interleukin-3 alpha receptor bound to the Fab fragment of antibody CSL362.

Authors:  Sophie E Broughton; Timothy R Hercus; Tracy L Nero; Urmi Dhagat; Catherine M Owczarek; Matthew P Hardy; Louis J Fabri; Pierre D Scotney; Andrew D Nash; Nicholas J Wilson; Angel F Lopez; Michael W Parker
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-02-19       Impact factor: 1.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.